Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy

Despite recent advances in oncology, diagnosis, and therapy, treatment of pancreatic ductal adenocarcinoma (PDAC) is still exceedingly challenging. PDAC remains the fourth leading cause of cancer-related deaths worldwide. Poor prognosis is due to the aggressive growth behavior with early invasion an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kretz, Anna-Laura, von Karstedt, Silvia, Hillenbrand, Andreas, Henne-Bruns, Doris, Knippschild, Uwe, Trauzold, Anna, Lemke, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876652/
https://www.ncbi.nlm.nih.gov/pubmed/29562636
http://dx.doi.org/10.3390/cancers10030077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876652/
https://www.ncbi.nlm.nih.gov/pubmed/29562636
http://dx.doi.org/10.3390/cancers10030077

Ejemplares similares